Biophysical Aspects of Auger Processes

References

• Adelstein S. J. Biophysical aspects of Auger processes: a review of the literature 1987–1991. Biophysical aspects of Auger processes, R. W. Howell, V. R. Narra, K. S. R. Sastry, D. V. Rao. American Institute of Physics, Inc., Woodburry, NY 1992; 1–13
   Google Scholar
• Auger P. Sur les rayons β secondaires produit dans un gaz des rayons X. Comp Rend 1925; 180: 65–8
   Google Scholar
• Hofer K. G., Prensky W., Hughes W. L. Death and metastatic distribution of tumor cells in mice monitored with 125I-iodo-deoxyuridine. J Natl Cancer Inst 1969; 43: 763–73
   PubMedGoogle Scholar
• Ertl H. H., Feinendegen L. E., Heiniger H. J. Iodine-125 a tracer in cell biology: physical properties and biological aspects. Phys Med Biol 1970; 15: 447–56
   PubMed Web of Science ®Google Scholar
• Feinendegen L. E., Ertl H. H., Bond V. P. Biological toxicity associated with the Auger effect. Proceedings of the Symposium on Biological Aspects of Radiation Quality, H. Ebert. IAEA., Vienna 1971; 419–30
   Google Scholar
• Hofer K. G., Hughes W. L. Radiotoxicity of intranuclear tritium, iodine-125, and iodine-131. Radiat Res 1971; 47: 94–109
   PubMed Web of Science ®Google Scholar
• Smith E. M., Harris C. C., Rohrer R. H. Calculation of local energy deposition due to electron capture and internal conversion. J Nucl Med 1966; 7: 23–31
   PubMed Web of Science ®Google Scholar
• Gillespie F. C., Orr J. S., Greig W. R. Microscopic dose distribution from 1–125 in the toxic thyroid gland and its relation to therapy. Br J Radiol 1970; 43: 40–7
   PubMed Web of Science ®Google Scholar
• Charlton D. E., Booz J. A Monte Carlo treatment of the decay of '-sl. Radiat Res 1981; 87: 10–23
   PubMed Web of Science ®Google Scholar
• Kassis Al, Adelstein S. J., Haydock C., Sastry K. S. R. Radiotoxicity of Se-75 and S-35: theory and application to a cellular model. Radiat Res 1980; 84: 407–25
   PubMed Web of Science ®Google Scholar
• Kassis Al, Adelstein S. J., Haydock C., Sastry K. S. R., McElvany K. D., Welch M. J. Lethality of Auger electrons from the decay of bromide-77 in the DNA of mammalian cells. Radiat Res 1982; 90: 363–73
   Web of Science ®Google Scholar
• Rao D. V., Govelitz G. F., Sastry K. S. R. Radiotoxicity of thallium-201 in mouse testes: inadequacy of conventional dosimetry. J Nucl Med 1983; 34: 145–53
   Google Scholar
• Rao D. V., Sastry K. S. R., Govelitz G. F., Grimmond H. E., Hill H. Z. In vivo effects of iron-55 and iron-59 on mouse testes: biophysical dosimetry of Auger electrons. J Nucl Med 1985; 26: 1456–65
   PubMed Web of Science ®Google Scholar
• Kassis AL, Sastry K. S. R., Adelstein S. J. Intracellular distribution and radiotoxicity of chromium-51 in mammalian cells: Auger electron dosimetry. J Nucl Med 1985; 26: 59–67
   PubMed Web of Science ®Google Scholar
• Rao D. V., Sastry K. S. R., Grimmond H. E., et al. Cytotoxicity of some indium radiopharmaceuticals in mouse testes. J Nucl Med 1988; 29: 375–84
   PubMed Web of Science ®Google Scholar
• Makrogiorgos G. M., Kassis Al, Baranowska-Kortylewicz J., et al. Radiotoxicity of 5-[I-125]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[I-123]iodo-2'-deoxyuridine. Radiat Res 1989; 118: 532–44
   PubMed Web of Science ®Google Scholar
• Howell R. W. Radiation spectra for Auger-electron emitting radionuclides: report No 2 of AAPM Nuclear Medicine Task Group No 6. Med Phys 1992; 19: 71–83
   PubMed Web of Science ®Google Scholar
• Humm J. L., Howell R. W., Rao D. V. Dosimetry of Auger-electron emitting radionuclides: report No 3 of AAPM Nuclear Medicine Task Group No 6. Med Phys 1994; 21: 1901–15
   PubMed Web of Science ®Google Scholar
• Weber D. A., Eckerman K. F., Dillman L. T., Ryman J. C. Radionuclide Data and Decay Schemes. Society of Nuclear Medicine, New York 1989, MIRD
   Google Scholar
• Pomplun E., Booz J., Charlton D. E. A Monte Carlo simulation of Auger cascades. Radiat Res 1987; 111: 533–52
   PubMed Web of Science ®Google Scholar
• Krisch R. E., Ley R. D. Induction of lethality and DNA breakage by the decay of iodine-125 in bacteriophage T4. Int J Radiat Biol 1974; 25: 21–30
   Web of Science ®Google Scholar
• Krisch R. E., Krasin F., Sauri C. J. DNA breakage, repair, and lethality of 125I decay in rec+and recA strains of Escherichia coli. Int J Radiat Biol 1976; 29: 37–50
   Web of Science ®Google Scholar
• Painter R. B., Young B. R., Burki H. J. Non-repairable strand breaks induced by 125I incorporated into mammalian DNA. Proc Natl Acad Sci USA 1974; 71: 4836–8
   PubMed Web of Science ®Google Scholar
• Martin R. F., Haseltine W. A. Range of radiochemical damage to DNA with decay of iodine-125. Science 1981; 213: 896–8
   PubMed Web of Science ®Google Scholar
• Yasui L. S. Nuclear lesions produced by 125I decay. Biophysical aspects of Auger processes, R. W. Howell, V. R Narra, K. S. R. Sastry, D. V. Rao. American Institute of Physics, Inc., Woodburry, NY 1992; 210–26
   Google Scholar
• Pomplun E. A new DNA target model for track structure calculations and its first application to I-125 Auger electrons. Int J Radiat Biol 1991; 59: 625–42
   PubMed Web of Science ®Google Scholar
• Paretzke H. G. Radiation track structure theory. Kinetics of inhomogeneous processes, G. R. Freeman. Wiley, New York 1987; 89–170
   Google Scholar
• Pomplun E., Roch M., Terrissol M. Simulation of strand break induction by DNA incorporated 125I. Biophysical aspects of Auger processes, R. W. Howell, V. R. Narra, K. S. R. Sastry, D. V. Rao. American Institute of Physics, Inc., Woodburry, NY 1992; 137–52
   Google Scholar
• Terrissol M. Modelling of radiation damage by 125l on a nucleosome. Int J Radiat Biol 1994; 66: 447–51
   PubMed Web of Science ®Google Scholar
• Pomplun E., Terrissol M. Low-energy electrons inside active DNA models: a tool to elucidate the radiation action mechanisms. Radiat Environ Biophys 1994; 33: 279–92
   PubMed Web of Science ®Google Scholar
• Charlton D. E., Humm J. L. A method of calculating initial DNA strand breakage following the decay of incorporated 125I. Int J Radiat Biol 1988; 53: 353–65
   Web of Science ®Google Scholar
• Makrigiorgos G. M., Berman R. M., Baranowska-Kortylewicz J., et al. DNA damage produced in V79 cells by DNA-incorporated iodine-123: a comparison with iodine-125. Radiat Res 1992; 129: 309–14
   PubMed Web of Science ®Google Scholar
• Sahu S. K., Kassis A. I., Makrigiorgos G. M., Baranowska-Kortylewicz J., Adelstein S. J. The effect of indium-111 decay on pBR322 DNA. Radiat Res 1995; 141: 193–8
   PubMed Web of Science ®Google Scholar
• Panyutin I. G., Neumann R. D. Sequence-specific DNA double-strand breaks induced by triplex forming 125I labeled oligonucleotides. Nucleic Acid Res 1994; 22: 4979–82
   PubMed Web of Science ®Google Scholar
• Miyazaki N., Fujiwara Y. Mutagenic and lethal effect of [5-125I]iodo-2'-deoxyuridine incorporated into DNA of mammalian cells and their RBEs. Radiat Res 1981; 88: 456–65
   PubMed Web of Science ®Google Scholar
• Little J. B., LeMotte P. K., Liber H. L. Quantitative studies of cytotoxicity, mutagenesis and oncologic transformation by radioisotopes incorporated into DNA. Human carcinogenesis, C. C. Harris, H. N. Auhup. Academic Press, New York 1983; 545–59
   Google Scholar
• Chan P. C., Lisco E., Lisco H., Adelstein S. J. The radiotoxicity of iodine-125 in mammalian cells. II. A comparative study on cell survival and cytogenetic responses to 125IUdR 131IUdR and 3H-TdR. Radiat Res 1976; 67: 322–43
   Web of Science ®Google Scholar
• Sundell-Bergman S., Bergman R., Johanson K. J. Chromosome damage induced by decay of 3H and 125I incorporated into DNA of Chinese hamster cells. Mutat Res 1985; 149: 257–63
   PubMed Web of Science ®Google Scholar
• Warters R. L., Hofer K. G. Radionuclide toxicity in cultured mammalian cells: elucidation of the primary site for radiation-induced mitotic delay. Radiat Res 1977; 69: 348–58
   PubMed Web of Science ®Google Scholar
• Schneiderman M. H., Hofer K. G. The target for radiation-induced division delay. Radiat Res 1980; 84: 462–76
   PubMed Web of Science ®Google Scholar
• Hofer K. G. Radiation biology and potential therapeutic applications of radionuclides. Bull Cancer 1980; 67: 343–53
   PubMed Web of Science ®Google Scholar
• Hofer K. G., Harris C. R., Smith J. M. Radiotoxicity of intracellular 67Ga, 125I, and 3H: nuclear versus cytoplasmic radiation effects in murine LI210 leukemia. Int J Radiat Biol 1975; 28: 225–41
   Web of Science ®Google Scholar
• Warters R. L., Hofer K. G., Harris C. R., Smith J. M. Radionuclide toxicity in cultured mammalian cells: elucidation of the primary target of radiation damage. Curr Top Radiat Res Q 1977; 12: 389–407
   Google Scholar
• Yasui L. S., Hofer K. G. Role of mitochondrial DNA in cell death induced by 125I decay. Int J Radiat Biol 1986; 49: 601–10
   Web of Science ®Google Scholar
• Hofer K. G., Keough G., Smith J. M. Biological toxicity of Auger emitters: molecular fragmentation vs. electron irradiation. Curr Top Radiat Res Q 1977; 12: 335–54
   Google Scholar
• Makrigiorgos G. M., Adelstein S. J., Kassis A. L. Limitation of conventional internal dosimetry at the cellular level. J Nucl Med 1989; 30: 1856–64
   PubMed Web of Science ®Google Scholar
• Goddu S. M., Howell R. W., Rao D. V. Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. J Nucl Med 1994; 35: 305–16
   Web of Science ®Google Scholar
• Faraggi M., Gardin I., de Labriolle-Vaylet C., Moretti J. L., Bok B. D. The influence of tracer localization on the electron dose rate delivered to the cell nucleus. J Nucl Med 1994; 35: 113–9
   PubMed Web of Science ®Google Scholar
• Jonkhoff A. R., Dieren E. B., Huijgens P. C., et al. Biological effectiveness of 67-gallium in HL60 cells compared with external low dose rate gamma irradiation: effects on proliferation, G2 arrest, and clonogenic capacity. Int J Radiat Oncol Biol Phys 1994; 30: 117–24
   PubMed Web of Science ®Google Scholar
• Ludwikow G., Ludwikow F., Johanson K. J. Kinetics of microtubule induction by 125I-labeled thyroid hormone in hormone-responsive cells. Int J Radiat Biol 1992; 61: 639–53
   PubMed Web of Science ®Google Scholar
• Narra V. R., Howell R. W., Harapanhalli R. S., Sastry K. S. R., Rao D. V. Radiotoxicity of some iodine-123, iodine-125, and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design. J Nucl Med 1992; 33: 2196–201
   PubMed Web of Science ®Google Scholar
• Narra V. R., Howell R. W., Sastry K. S. R., Rao D. V. Auger electron emitters as tools for elucidating the location of primary radiosensitive targets. Radiat Prot Dosim 1994; 52: 229–32
   Web of Science ®Google Scholar
• Howell R. W., Rao D. V., Hou D. Y., Narra V. R., Sastry K. S. R. The question of relative biological effectiveness and quality factor for Auger emitters incorporated into proliferating mammalian cells. Radiat Res 1991; 128: 282–92
   PubMed Web of Science ®Google Scholar
• Kassis A. I., Makrigiorgos G. M., Adelstein S. J. Implications of radiobiologic and dosimetric studies of DNA-incorporated 123I: the use of the Auger effect as a biologic probe at the nanometre level. Radiat Prot Dosim 1990; 31: 333–8
   Web of Science ®Google Scholar
• Kassis A. I., Fayad F., Kinsey B. M., Sastry K. S. R., Adelstein S. J. Radiotoxicity of an I-125-labeled DNA intercalator in mammalian cells. Radiat Res 1989; 118: 283–94
   PubMed Web of Science ®Google Scholar
• McLean R. N., Wilkinson D. The radiation dose to cells in vitro from intracellular indium-Ill. Biochem Cell Biol 1989; 67: 661–5
   PubMed Web of Science ®Google Scholar
• Rao D. V., Narra V. R., Howell R. W., Lanka V. K., Sastry K. S. R. Induction of spermhead abnormalities by incorporated radionuclides: dependence on subcellular distribution, type of radiation, dose rate and presence of radioprotectors. Radiat Res 1991; 125: 89–97
   PubMed Web of Science ®Google Scholar
• Narra V. R., Harapanhalli R. S., Howell R. W., Sastry K. S. R., Rao D. V. Vitamins as radioprotectors in vivo: I. Protection by vitamin C against internal radionuclides in mouse testes: implications to the mechanism of the Auger effect. Radiat Res 1994; 137: 394–9
   PubMed Web of Science ®Google Scholar
• Narra V. R., Harapanhalli R. S., Goddu S. M., Howell R. W., Rao D. V. Radioprotection against biological effects of internal radionuclides in vivo by S-(2-aminoethyl)isothioronium bromide hydrobromide (AET). J Nucl Med 1995; 36: 259–66
   PubMed Web of Science ®Google Scholar
• Harapanhalli R. S., Narra V. R., Yaghmai V., et al. Vitamins as radioprotectors in vivo. II. Protection by vitamin A and soybean oil against radiation damage caused by internal radionuclides. Radiat Res 1994; 139: 115–22
   Google Scholar
• Hofer K. G., VanLoon N., Schneiderman M. H., Charlton D. E. The paradoxical nature of DNA damage and cell death induced by 125I decay. Radiat Res 1992; 130: 121–4
   PubMed Web of Science ®Google Scholar
• Hofer K. G., VanLoon N., Schneiderman M. H., Charlton D. E. High LET and low LET cytocidal effects of DNA-associated iodine-125. Biophysical aspects of Auger processes, R. W. Howell, V. R. Narra, K. S. R. Sastry, D. V. Rao. American Institute of Physics, Inc., Woodburry, NY 1992; 227–48
   Google Scholar
• Hofer K. G., Bao S. P. Low-LET and high-LET radiation action of 125I decays in DNA: effect of cysteamine on micronucleus formation and cell death. Radiat Res 1995; 141: 183–92
   PubMed Web of Science ®Google Scholar
• Howell R. W., Rao D. V., Sastry K. S. R. Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumors. Med Phys 1989; 16: 66–74
   PubMed Web of Science ®Google Scholar
• Strand S. E., Jönsson B. A., Ljungberg M., Tennvall J. Radioimmunotherapy dosimetry—a review. Acta Oncol 1993; 32: 807–17
   PubMed Web of Science ®Google Scholar
• Humm J. L., Macklis R. M., Lu X. Q., et al. The spatial accuracy of cellular dose estimates obtained from 3D reconstructed tissue autoradiographs. Phys Med Biol 1995; 40: 163–80
   PubMed Web of Science ®Google Scholar
• Schneiderman M. H., Schneidermann G. S. Radioiodo-deoxyuridine in cancer therapy: an in vitro approach to developing in vivo strategies. J Nucl Med 1996; 37((Suppl.))65–95
   Google Scholar
• Klecker RW, Jr, Jenkins J. F., Kinsella T. J., Fine R. L., Strong J. M., Collins J. M. Clinical pharmacology of 5-iodo-2'-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation. Clin Pharmacol Ther 1985; 38: 45–51
   PubMed Web of Science ®Google Scholar
• Prusoff W. H. A review of some aspects of 5-125I-iodo-deoxyuridine and azauridine. Cancer Res 1963; 23: 1246–59
   PubMed Web of Science ®Google Scholar
• Van den Abbeele A. D., Baranowska-Kortylewicz J., Adelstein S. J., . Diagnostic and therapeutic applications of Auger electron emitting 5-[123I/125I]iodo-2'-deoxyuridine in cancer. Biophysical aspects of Auger processes, R. W. Howell, V. R. Narra, K. S. R. Sastry, D. V. Rao, et al. American Institute of Physics, Inc., Woodburry, NY 1992; 372–95
   Google Scholar
• Kassis A. I., Van den Abbeele A. D., Wen P. Y. C., et al. Specific uptake of the Auger electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans. Cancer Res 1990; 50: 5199–203
   PubMed Web of Science ®Google Scholar
• Mariani G., Cei A., Collechi P., et al. Tumor targeting in vivo and metabolic fate of 5-[iodo-125]-iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer. J Nucl Med 1993; 34: 1175–83
   PubMed Web of Science ®Google Scholar
• Mariani G., Giuliani L., Baranowska-Kortylewicz J., . Intratumoral injection of 5-[125I]iodo-2'-deoxyuridine in patients with breast cancer. Radioactive isotopes in clinical medicine and research, R. Höfer, H. Bergmann, H. Sinzinger, et al. Schattauer, Stuttgart—New York 1993; 188–93
   Google Scholar
• Wheldon T. E. Targeting radiation to tumours. Int J Radiat Biol 1994; 65: 109–15
   PubMed Web of Science ®Google Scholar
• Bloomer W. D., McLaughlin W. H., Weichselbaum R. R., Hanson R. N., Adelstein S. J., Seitz D. E. The role of subcellular localization in assessing the cytotoxicity of iodine-125 labeled iodo-deoxyuridine iodotamoxifen and iodoantipyrine. J Radioanal Chem 1981; 65: 209–21
   Web of Science ®Google Scholar
• McLaughlin W. H., Milius R. A., Pillai K. M. R., Edasery J. P., Blu-Menthal RD, Bloomer W. D. Cytotoxicity of receptor-mediated 16α[125I]iodo-estradiol in cultured MCF-7 human breast cancer cells. J Natl Cancer Inst 1989; 81: 437–40
   PubMedGoogle Scholar
• DeSombre E. R., Shan B., Hanson R. N., Kiuvanen P. C., Hughes A. Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose. Cancer Res 1992; 52: 5752–8
   PubMed Web of Science ®Google Scholar
• Ozanne B. W., Richards C. S., Hendler F. J., Burns D., Gustersen B. Over-expression of the EGF receptor is a hall-mark of squamous cell carcinomas. J Pathol 1986; 149: 9–14
   PubMed Web of Science ®Google Scholar
• Howell R. W., Kassis A. I., Adelstein S. J., et al. Radiotoxicity of platinum-195m-labeled trans-platinum (II) in mammalian cells. Radiat Res 1994; 140: 55–62
   PubMed Web of Science ®Google Scholar
• Helene C. The anti-gene strategy: control of gene expression by triplex-forming oligonucleotides. Anti-Cancer Drug Design 1991; 6: 569–84
   PubMedGoogle Scholar
• Feinendegen L. E. Biological damage from the Auger effect possible benefits. Radiat Environ Biophys 1975; 12: 85–99
   PubMed Web of Science ®Google Scholar